Relationship Between Cardiovascular Events and Serum Lipid and Plasma Fatty Acid Profile in Maintenance Hemodialysis

Norio Nakamura1, Hiroshi Osawa2, Daiki Nagawa3

  • 1Department of Nursing Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Japan; nnakamur@r2.dion.ne.jp.

Insights

Cardiovascular disease (CVD) in hemodialysis (HD) patients with diabetic kidney disease (DKD) is linked to abnormal fatty acid balance. Specifically, lower levels of alpha-linolenic acid (ALA) and docosapentaenoic acid (DPA) are associated with CVD events.

Area of Science:

  • Nephrology
  • Cardiology
  • Diabetology

Background:

  • Cardiovascular disease (CVD) is a significant complication for patients undergoing hemodialysis (HD), particularly those with diabetes mellitus (DM).
  • Diabetic kidney disease (DKD) is a common cause for initiating dialysis treatment.

Purpose of the Study:

  • To investigate the association between cardiovascular events and the lipid and fatty acid profiles in maintenance HD patients with DKD.
  • To compare these profiles between patients with and without a history of cardiovascular events.

Main Methods:

  • A cohort of 123 maintenance HD patients with DKD was studied.
  • Patients were divided into a CVD group (n=53) and a non-CVD group (n=70) based on cardiovascular event history.
  • Serum lipid profiles (Total Cholesterol, Triglycerides, HDL-C, LDL-C) and plasma fatty acid compositions (24 fractions) were measured and compared between groups.

Main Results:

  • Total cholesterol and triglycerides were significantly lower in the CVD group compared to the non-CVD group.
  • Plasma levels of alpha-linolenic acid (ALA) and docosapentaenoic acid (DPA) were significantly lower in the CVD group.
  • These findings suggest a potential link between specific fatty acid deficiencies and cardiovascular events in this patient population.

Conclusions:

  • Abnormal fatty acid balance, characterized by low levels of ALA and DPA, appears more strongly associated with cardiovascular events in maintenance HD patients with DKD than traditional serum lipid levels.
  • These findings highlight the importance of evaluating fatty acid profiles in DKD patients on HD to better understand and potentially mitigate cardiovascular risk.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
43
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
209
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
47
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
57
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
85
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16